Suven Life Sciences an ISO 9001, ISO 14001 and OHSAS 18001 company has received United States Food and Drugs Administration (US FDA) acceptance for its facility in Pashamylaram, near Hyderabad. The company has undergone US FDA renewal inspection at their facility in Pashamylaram for the manufacture and supply of active pharmaceutical ingredients (bulk drugs), ntermediates and formulations under cGMP.
Based on the inspection and the review thereafter US-FDA has classified Suven facility at Pashamylaram as acceptable for manufacture and supply of active pharmaceutical ingredients, intermediates and formulations. So far Suven Life Sciences has filed 29 DMF’s and 1 ANDA from this facility which is FDA complaint under cGMP and continued after renewal inspection.
Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: